US Stock MarketDetailed Quotes
THAR Tharimmune
- 2.400
- -0.080-3.23%
Close Oct 1 16:00 ET
2.76MMarket Cap0.12P/E (TTM)
2.520High2.350Low15.55KVolume2.500Open2.480Pre Close37.52KTurnover1.37%Turnover RatioLossP/E (Static)1.15MShares142.50052wk High0.41P/B2.72MFloat Cap2.25052wk Low--Dividend TTM1.13MShs Float1590.000Historical High--Div YieldTTM6.86%Amplitude2.250Historical Low2.413Avg Price1Lot Size
Tharimmune Stock Forum
Sign in to post a comment
$Tharimmune (THAR.US)$ Reuters· just
Tharimmune Signs Nonbinding Letter of Intent to Merge With Intract Pharma
Tharimmune Signs Nonbinding Letter of Intent to Merge With Intract Pharma
2
2
$Tharimmune (THAR.US)$ Reuters· 3 mins ago
Tharimmune Acquires Global License & Partners With Intract Pharma to Develop Oral Formulation of Infliximab
Tharimmune Acquires Global License & Partners With Intract Pharma to Develop Oral Formulation of Infliximab
4
$Tharimmune (THAR.US)$ Guess i will break even later.. Held too long..
loading...
1
2
1
2
$Tharimmune (THAR.US)$
Tharimmune Launches New Website as Discussions with FDA Continue for Phase 2 Clinical Trial with TH104
Tharimmune (NASDAQ:THAR), a clinical-stage biotech company, has launched a new website at www.tharimmune.com. The redesigned platform offers comprehensive information about the company's research, clinical trials, and corporate developments. CEO Randy Milby emphasized the website's role in enhancing communication with stakeholders.
Concurrently, Tharimmune is continui...
Tharimmune Launches New Website as Discussions with FDA Continue for Phase 2 Clinical Trial with TH104
Tharimmune (NASDAQ:THAR), a clinical-stage biotech company, has launched a new website at www.tharimmune.com. The redesigned platform offers comprehensive information about the company's research, clinical trials, and corporate developments. CEO Randy Milby emphasized the website's role in enhancing communication with stakeholders.
Concurrently, Tharimmune is continui...
No comment yet
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
EUGENE啊梁 : Not taking off.
Trytosaveabit OP EUGENE啊梁 : Only PM! So hard to trade! Only a fraction of traders are/can trade!